Skip to main content
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · TARS ISIN · US87650L1035 US Manufacturing
Open in API
Filings indexed 576 across all filing types
Latest filing 2023-06-21 Regulatory Filings
Country US United States of America
Listing US TARS

About Tarsus Pharmaceuticals, Inc.

https://www.tarsusrx.com/

Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for diseases with limited treatment options. The company's initial focus is on eye care. Its lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, is the first and only FDA-approved treatment for Demodex blepharitis. Tarsus is also advancing a pipeline of potential treatments for other conditions with high unmet needs, including ocular rosacea, Lyme disease prevention, and other indications across dermatology and infectious diseases.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2023
Regulatory Filings
2023-06-21 English
FORM 4
Director's Dealing
2023-06-16 English
Regulatory Filings 2023
Regulatory Filings
2023-06-15 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 15, 2023. It includes a Regulation FD Disclosure about a Virtual Investor Webcast and a corporate presentation related to the company's commercialization strategy and product plans. The document explicitly states that the presentation is filed as Exhibit 99.1 and is being furnished, not filed, indicating it is supplementary information rather than a full report. The content focuses on investor communication and presentation material rather than detailed financial statements or management discussion. The document length is 3765 characters, which is relatively short and consistent with an announcement or presentation filing rather than a full financial report. Therefore, the most appropriate classification is Investor Presentation (IP).
2023-06-15 English
Regulatory Filings 2023
Regulatory Filings
2023-06-14 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-12 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.